Metopirone 250 mg/1
Metyrapone · CAPSULE, GELATIN COATED · HRA Pharma Rare Diseases
No Recall History
Plain English
Metopirone is a capsule, gelatin coated containing metyrapone at 250 mg/1, taken oral. Manufactured by HRA Pharma Rare Diseases.
Key Facts
- Brand Name
- Metopirone
- Generic Name
- Metyrapone
- NDC Code (Product)
76336-455- Manufacturer
- HRA Pharma Rare Diseases
- Strength
- 250 mg/1
- Dosage Form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA012911
- Drug Class
- Adrenal Steroid Synthesis Inhibitor [EPC]
- Marketing Start
- 01/25/1962
Recall History
No Recall HistoryFrequently Asked Questions
What is Metopirone used for?
Metopirone contains Metyrapone. It is a capsule, gelatin coated taken oral. Consult your doctor for specific uses.
Is Metopirone a controlled substance?
Metopirone is not classified as a controlled substance by the DEA.
What is the generic name for Metopirone?
The generic name for Metopirone is Metyrapone. There are no other listed brand versions of Metyrapone.
What is the NDC code for Metopirone 250 mg/1?
The NDC (National Drug Code) for Metopirone 250 mg/1 is 76336-455, listed by HRA Pharma Rare Diseases.
Other Metopirone Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)